We are live on
!
Find out more
IA
IFG Advisory Portfolio holdings
AUM
$34.9M
1-Year Est. Return
20.48%
This Fund
S&P 500
This Quarter
Est. Return
+6.43%
1 Year Est. Return
+20.48%
3 Year Est. Return
+56.88%
5 Year Est. Return
+63.29%
10 Year Est. Return
–
AUM
$548M
AUM Growth
+$32.2M
(+6.3%)
Cap. Flow
+$1.31M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
423
New
28
Increased
147
Reduced
201
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Capital Strength ETF
FTCS
|
+$1.5M |
| 2 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$1.29M |
| 3 |
First Trust Value Line Dividend Fund
FVD
|
+$1.25M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$836K |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$768K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.17M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$593K |
| 3 |
Waste Management
WM
|
+$575K |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$557K |
| 5 |
Microsoft
MSFT
|
+$553K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.66% |
| 2 | Technology | 5.59% |
| 3 | Financials | 5.02% |
| 4 | Industrials | 3.8% |
| 5 | Consumer Discretionary | 3.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Medtronic
MDT
$107B
| $1.4M | 0.26% |
12,368
+243
| +2% | +$26.7K |
|
102
Pfizer
PFE
$140B
| $1.39M | 0.25% |
37,384
-5,112
| -12% | -$182K |
|
103
Duke Energy
DUK
$102B
| $1.39M | 0.25% |
15,187
-1,740
| -10% | -$160K |
|
104
Gentex
GNTX
$4.88B
| $1.36M | 0.25% |
47,017
-317
| -0.7% | -$8.93K |
|
105
State Street Global Allocation ETF
GAL
$302M
| $1.34M | 0.25% |
33,560
+1,110
| +3% | +$43.7K |
|
106
Eastman Chemical
EMN
$7.8B
| $1.32M | 0.24% |
16,654
+415
| +3% | +$31.9K |
|
107
Amplify Online Retail ETF
IBUY
$106M
| $1.32M | 0.24% |
25,709
+366
| +1% | +$17.8K |
|
108
McDonald's
MCD
$188B
| $1.25M | 0.23% |
6,351
-1,236
| -16% | -$245K |
|
|
HDV
109
iShares Core High Dividend ETF
HDV
$14.4B
| $1.25M | 0.23% |
63,810
-655
| -1% | -$12.5K |
|
110
MSC Industrial Direct
MSM
$7.02B
| $1.25M | 0.23% |
15,918
+483
| +3% | +$35.7K |
|
111
Lowe's Companies
LOW
$116B
| $1.21M | 0.22% |
10,115
-445
| -4% | -$50.9K |
|
112
Bank of America
BAC
$435B
| $1.21M | 0.22% |
34,257
-1,303
| -4% | -$42.1K |
|
113
Philip Morris
PM
$301B
| $1.2M | 0.22% |
14,067
-344
| -2% | -$28.4K |
|
114
T. Rowe Price
TROW
$25B
| $1.19M | 0.22% |
9,786
-86
| -0.9% | -$10.2K |
|
115
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.66B
| $1.19M | 0.22% |
30,087
+2,438
| +9% | +$94K |
|
116
Cognizant
CTSH
$21.5B
| $1.18M | 0.21% |
18,950
+300
| +2% | +$18.5K |
|
117
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $1.17M | 0.21% |
17,013
-320
| -2% | -$21.1K |
|
118
iShares Russell 3000 ETF
IWV
$19.5B
| $1.17M | 0.21% |
6,209
-44
| -0.7% | -$7.93K |
|
119
iShares Core MSCI Total International Stock ETF
IXUS
$57.5B
| $1.15M | 0.21% |
18,503
+388
| +2% | +$23.3K |
|
120
Analog Devices
ADI
$181B
| $1.14M | 0.21% |
9,572
+213
| +2% | +$24K |
|
121
Pacer US Cash Cows 100 ETF
COWZ
$18.2B
| $1.13M | 0.21% |
36,520
-1,131
| -3% | -$34.1K |
|
122
General Mills
GIS
$19.2B
| $1.13M | 0.21% |
21,126
+1,320
| +7% | +$69.5K |
|
123
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $1.13M | 0.21% |
25,592
-3,765
| -13% | -$161K |
|
124
Enbridge
ENB
$124B
| $1.12M | 0.2% |
28,206
-4,170
| -13% | -$156K |
|
125
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $1.11M | 0.2% |
25,034
+1,146
| +5% | +$48.6K |
|
Similar funds
CPR
VVVM4
ACM
DVF
AP
CWM
CM
RF
IFG Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, IFG Advisory held 423 positions worth $548M, up 6.3% from $516M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
IFG Advisory's Q4 2019 filing shows 28 new, 147 increased, 201 reduced and 16 closed positions. Its largest new stake was Neurocrine Biosciences: 4,607 shares worth $495K. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.17M.
By sector, the portfolio is most concentrated in Healthcare at 5.7% of assets, up from 5.1% a quarter earlier, followed by Technology and Financials.
- IFG Advisory's largest Q4 2019 buy was Neurocrine Biosciences: 4,607 shares worth $495K.
- IFG Advisory added most to First Trust Capital Strength ETF in Q4 2019, an estimated $1.5M increase.
- IFG Advisory's biggest Q4 2019 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.17M.
- IFG Advisory fully exited Waste Management in Q4 2019, selling an estimated $575K.
- IFG Advisory's ten largest holdings make up 24% of its $548M portfolio in Q4 2019.
- IFG Advisory opened 28 new positions and closed 16 in Q4 2019.
- IFG Advisory's portfolio value rose 6.3% quarter-over-quarter to $548M.
Based on IFG Advisory's 13F filing for Q4 2019, filed 7 Feb 2020.